TRPM7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.920310E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.856250E-01
Normal-vs-Stage2
2.440400E-02
Normal-vs-Stage3
9.443700E-03
Normal-vs-Stage4
1.374160E-01
Stage1-vs-Stage2
3.397600E-01
Stage1-vs-Stage3
2.659700E-02
Stage1-vs-Stage4
5.306600E-01
Stage2-vs-Stage3
3.725000E-03
Stage2-vs-Stage4
9.533000E-01
Stage3-vs-Stage4
1.331610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.300100E-02
Normal-vs-AfricanAmerican
6.396100E-02
Normal-vs-Asian
1.336170E-02
Caucasian-vs-AfricanAmerican
9.251400E-01
Caucasian-vs-Asian
1.193190E-01
AfricanAmerican-vs-Asian
3.466800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.453800E-02
Normal-vs-Female
1.851880E-02
Male-vs-Female
4.720200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.626800E-01
Normal-vs-Age(41-60Yrs)
3.047900E-02
Normal-vs-Age(61-80Yrs)
2.268100E-02
Normal-vs-Age(81-100Yrs)
1.149690E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.788400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.060000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.647420E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.098800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.165800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.660600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.884100E-03
Normal-vs-Daily Drinker
7.577500E-03
Normal-vs-Weekly Drinker
3.666200E-02
Normal-vs-Occasional Drinker
1.786400E-02
Normal-vs-Social Drinker
5.986400E-02
Non Drinker-vs-Daily Drinker
5.982200E-01
Non Drinker-vs-Weekly Drinker
8.434600E-01
Non Drinker-vs-Occasional Drinker
5.974400E-01
Non Drinker-vs-Social Drinker
3.800000E-01
Daily Drinker-vs-Weekly Drinker
8.437400E-01
Daily Drinker-vs-Occasional Drinker
3.773600E-01
Daily Drinker-vs-Social Drinker
2.605000E-01
Weekly Drinker-vs-Occasional Drinker
5.974000E-01
Weekly Drinker-vs-Social Drinker
4.547000E-01
Occasional Drinker-vs-Social Drinker
7.289800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.962100E-02
Normal-vs-Grade 2
3.442700E-03
Normal-vs-Grade 3
5.415600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.439200E-01
Grade 1-vs-Grade 3
6.559000E-01
Grade 1-vs-Grade 4
5.962100E-02
Grade 2-vs-Grade 3
9.819800E-01
Grade 2-vs-Grade 4
3.442700E-03
Grade 3-vs-Grade 4
5.415600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.629500E-02
Normal-vs-NonDiabetic
8.260300E-03
Diabetic-vs-NonDiabetic
7.912200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.575500E-03
Normal-vs-NoPancreatitis
1.621730E-02
Pancreatitis-vs-NoPancreatitis
3.487400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.717750E-02
Normal-vs-N1
2.586000E-02
N0-vs-N1
4.667000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.872300E-02
Normal-vs-TP53-NonMutant
1.450050E-01
TP53-Mutant-vs-TP53-NonMutant
2.701600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
